National Decision Support Co. competitors

Mr. Michael Klein serves as the Chairman and CEO for iCAD Medical (Nasdaq: ICAD), a clinical artificial intelligence company focused on the detection of breast cancer and other proliferative diseases. iCAD's, therapy subsidiary, Xoft Inc. uses novel electronic brachytherapy for the treatment of breast and gynecological cancers as well as brain, rectal and prostate cancers. Between December 2014 and October 2018, when he assumed the above position, Mr. Klein served as Chief Executive Officer at Inflection Point Consulting, an executive coaching and consulting firm with a focus on medical technology, biopharma and healthcare services. During this same time period, Mr. Klein served as a Adjunct Professor at the Leavey School of Business at Santa Clara University. Prior to that, from December 2011 to November 2014. Klein was the Chief Executive Officer at SonaCare Medical, LLC (f/k/a US HIFU, LLC), a global leader in minimally invasive high intensity focused ultrasound technologies used for the treatment of prostate and other urological cancers. From April 2011 to December 2011, Mr. Klein was the President of the Civco Radiation Oncology Division within Roper Industries, a diversified industrial company that produces engineered products for global niche markets. He was President and Chief Executive Officer of Xoft, Inc., a medical device company, a position he held from December 2004 until the sale of Xoft to iCAD Medical in December 2010. Prior to joining Xoft, from 2000 to 2004, Mr. Klein served as Chairman, President and Chief Executive Officer of R2 Technology, Inc., a breast and lung cancer computer aided detection company. The first company to bring a medical artificial intelligence technology before the FDA and receive PMA Regulatory Approval. Previously, Mr. Klein served in VP, Sales and Marketing roles at Varian Medical Systems (VAR) and Becton Dickinson (BDX). Mr. Klein received a Bachelor of Arts degree from the University at Albany, SUNY. Mr. Klein also received his M.B.A. from the New York Institute of Technology and completed his post-graduate Executive Education Studies at Harvard University and Babson College. Mr. Klein lives in Mountain View, California with his wife and 3 children, in close proximity. Mr. Klein splits time between iCAD headquarters in Nashau, NH and Xoft’s headquarters in San Jose, CA.

Paul B. Domorski was named President and Chief Executive Officer of PAR Technology Corp. in April 2011. He also joined the Company’s Board of Directors as Chairman. Mr. Domorski brings significant leadership experience to PAR. Most recently, he was president, chief executive officer and a director of EMS Technologies, a publicly traded company recently acquired by Honeywell. EMS was named one of Forbes 200 “best small companies” during his tenure. Prior to joining EMS, he was vice president of Avaya Corporation’s $1.6 billion services operations business responsible for service and support operations worldwide. Previously, he served as president and chief executive officer during the restructuring of RSL Communications Ltd., an international provider of communications services. Mr. Domorski spent nearly 10 years internationally including as president of Syncordia, British Telecom’s rapidly growing global outsourcing and network integration business, and head of Unisys EMEA services business. He began his career at Unisys Corporation and its predecessor companies, Burroughs and Memorex, holding progressively more responsible executive and financial roles there. Mr. Domorski holds Master’s degrees in Organizational Dynamics from the University of Pennsylvania and Master’s and Bachelor degrees from The American University, where he was one of their youngest graduates ever. He is an alumnus of the Wharton Business School, having attended their advanced management program. He was a board member, on the executive committee, and served briefly as Vice Chairman of TechAmerica, which was formerly called The American Electronics Association and has written an article for the Harvard Business Review.

David Osborne is a Chief Executive Officer at RedBrick Health.